Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lifevantage Corporation stock logo
LFVN
Lifevantage
$6.41
+5.8%
$6.14
$3.90
$15.00
$80.89M0.69327,435 shs466,917 shs
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$20.12
+0.2%
$23.51
$12.97
$28.14
$353.71M0.86121,469 shs138,239 shs
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
$2.28
+8.1%
$2.70
$1.80
$3.22
$132.01M1.45625,371 shs7.16 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lifevantage Corporation stock logo
LFVN
Lifevantage
+0.33%-36.08%+16.76%+28.12%-52.28%
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
0.00%-1.91%-9.75%-16.40%+34.95%
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
-23.83%-16.93%-18.22%-14.57%-27.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lifevantage Corporation stock logo
LFVN
Lifevantage
$6.41
+5.8%
$6.14
$3.90
$15.00
$80.89M0.69327,435 shs466,917 shs
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$20.12
+0.2%
$23.51
$12.97
$28.14
$353.71M0.86121,469 shs138,239 shs
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
$2.28
+8.1%
$2.70
$1.80
$3.22
$132.01M1.45625,371 shs7.16 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lifevantage Corporation stock logo
LFVN
Lifevantage
+0.33%-36.08%+16.76%+28.12%-52.28%
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
0.00%-1.91%-9.75%-16.40%+34.95%
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
-23.83%-16.93%-18.22%-14.57%-27.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lifevantage Corporation stock logo
LFVN
Lifevantage
2.00
Hold$5.00-22.00% Downside
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
2.67
Moderate Buy$35.0073.96% Upside
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
1.50
ReduceN/AN/A

Current Analyst Ratings Breakdown

Latest LFVN, SPRO, and NATR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
DowngradeBuy (B-)Hold (C+)
5/26/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
UpgradeHold (C-)Hold (C)
5/26/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
DowngradeBuy (B)Buy (B-)
5/11/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
UpgradeBuy (B-)Buy (B)
5/11/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
Reiterated RatingBuy$33.00
5/8/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
Set Price Target$37.00
5/7/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
DowngradeBuyHold$5.00
5/4/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
DowngradeHold (C)Hold (C-)
4/21/2026
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
Reiterated RatingSell (D-)
3/27/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
Reiterated RatingHold (C)
3/20/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
UpgradeHold (C+)Buy (B-)
(Data available from 6/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lifevantage Corporation stock logo
LFVN
Lifevantage
$228.53M0.35$1.17 per share5.49$2.75 per share2.33
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$480.14M0.74$2.18 per share9.24$9.23 per share2.18
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
$66.80M1.98$0.13 per share18.21$1.05 per share2.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lifevantage Corporation stock logo
LFVN
Lifevantage
$9.81M$0.4514.249.86N/A2.94%23.89%12.47%9/3/2026 (Estimated)
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$19.52M$1.1018.29N/AN/A4.06%14.67%9.27%7/30/2026 (Estimated)
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
$8.57M$0.249.50N/AN/A24.90%35.58%24.95%8/11/2026 (Estimated)

Latest LFVN, SPRO, and NATR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
-$0.18-$0.13+$0.05-$0.13$0.26 million$0.26 million
5/7/2026Q1 2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$0.2050$0.30+$0.0950$0.29$122.15 million$122.89 million
5/6/2026Q3 2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.16$0.12-$0.04$0.11$47.77 million$43.72 million
3/26/2026Q4 2025
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
-$0.20$0.53+$0.73$0.53$26.00 million$41.30 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.203.12%N/A44.44%3 Years
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
N/AN/AN/AN/AN/A
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
N/AN/AN/AN/AN/A

Latest LFVN, SPRO, and NATR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/27/2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
quarterly$0.052.12%6/1/20266/1/20266/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lifevantage Corporation stock logo
LFVN
Lifevantage
N/A
1.96
1.04
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
N/A
2.50
1.56
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
N/A
10.50
10.50

Institutional Ownership

CompanyInstitutional Ownership
Lifevantage Corporation stock logo
LFVN
Lifevantage
35.32%
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
79.40%
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
25.60%

Insider Ownership

CompanyInsider Ownership
Lifevantage Corporation stock logo
LFVN
Lifevantage
21.95%
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
3.10%
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
2.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Lifevantage Corporation stock logo
LFVN
Lifevantage
26012.62 million9.85 millionOptionable
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
85017.58 million17.04 millionOptionable
Spero Therapeutics, Inc. stock logo
SPRO
Spero Therapeutics
15057.90 million56.22 millionOptionable

Recent News About These Companies

Biggest stock movers Thursday: INTC, KR, ACN, and more
FDA approves first oral carbapenem therapy for cUTIs

New MarketBeat Followers Over Time

Media Sentiment Over Time

Lifevantage stock logo

Lifevantage NASDAQ:LFVN

$6.41 +0.35 (+5.78%)
Closing price 04:00 PM Eastern
Extended Trading
$6.36 -0.05 (-0.72%)
As of 06:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

Nature's Sunshine Products stock logo

Nature's Sunshine Products NASDAQ:NATR

$20.12 +0.04 (+0.20%)
Closing price 04:00 PM Eastern
Extended Trading
$20.12 0.00 (0.00%)
As of 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

Spero Therapeutics stock logo

Spero Therapeutics NASDAQ:SPRO

$2.28 +0.17 (+8.06%)
Closing price 04:00 PM Eastern
Extended Trading
$2.25 -0.03 (-1.32%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, an intravenous-administered antibiotic against MDR Gram-negative pathogens comprising carbapenem-resistant enterobacterales (CRE), acinetobacter baumannii, and pseudomonas aeruginosa, as well as negative bacterial infections in the hospital setting; and SPR720, a novel oral antibiotic agent for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.